Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways

BACKGROUND: Keto-analogues administration plays an important role in clinical chronic kidney disease (CKD) adjunctive therapy, however previous studies on their reno-protective effect mainly focused on kidney pathological changes induced by nephrectomy. This study was designed to explore the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng, Xu, Huzi, Chong Lee Shin, Octavia Li-Sien, Li, Li, Gao, Hui, Zhao, Zhi, Zhu, Fan, Zhu, Han, Liang, Wangqun, Qian, Kun, Zhang, Chunxiu, Zeng, Rui, Zhou, Hanjing, Yao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458753/
https://www.ncbi.nlm.nih.gov/pubmed/30975176
http://dx.doi.org/10.1186/s12967-019-1856-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458753/
https://www.ncbi.nlm.nih.gov/pubmed/30975176
http://dx.doi.org/10.1186/s12967-019-1856-9

Ejemplares similares